Circulating antibodies and antigens correlate with egg counts in human fascioliasis

Tropical Medicine and International Health

Volumn 4, Issue 10, 1999, Pages 691-694

  Shehab, A Y ^a   Abou Basha, L M ^a   El Morshedy, H N ^b   Abdel Fattah, M ^a   Osman, M M ^a   Farag, H F ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b High Institute of Public Health Egypt   (Egypt)

Author keywords

Antibodies; Circulating antigens; Egg counts; Human fascioliasis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FASCIOLA GIGANTICA; FASCIOLIASIS; FECES ANALYSIS; HUMAN;

ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASCIOLIASIS; HUMANS; MORBIDITY; PARASITE EGG COUNT; SEROLOGIC TESTS;

EID: 0032759224     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1999.00466.x     Document Type: Article

References (17)

1. Abdel-Hafez SK, Phillips SM & Zodda DM (1983) Detection and characterization of schistosome derived antigens by inhibition enzyme linked immunosorbent assay (IELISA). Experimental Parasitology 55, 219-232.
2. Ariona R, Riancho JA, Aguado JM, Salesa R & Gonzalez-Macias J (1995) Fascioliasis in developed countries. A review of classic and aberrant forms of the disease. Medicine 74, 13-23.
3. Barakat RM, El-Gassim EE, Awadalla HN, El-Molla A & Omar EA (1983) Evaluation of enzyme linked immunosorbent assay (ELISA) as a diagnostic tool for schistosomiasis. Transactions of the Royal Society for Tropical Medicine and Hygiene 77, 109-111.
4. Bendezu P, Frame A & Hillyer GV (1982) Human fascioliasis in Corozal, Puerto Rico. Journal of Parasitology 68, 297-299.
5. De Mol P, Hemelhof W, Retore P et al. (1985) A competitive immunosorbent assay for the detection of heat-stable enterotoxin of Escherichia coli. Journal of Medical Microbiology 20, 69-74.
6. Deelder AM, De Jonge N, Boerman OC et al. (1989) Sensitive determination of circulating anodic antigen in Schistosoma mansoni infected individuals by an enzyme-linked immunosorbent assay using monoclonal antibodies. American Journal of Tropical Medicine and Hygiene 40, 268-272.
7. Farag HE Salem A. El-Hifni SA & Kandil M (1988) Bithionol (Bitin) treatment in established fascioliasis in Egyptians, Journal of Tropical Medicine and Hygiene 91, 240-244.
8. Knobloch J (1985) Human fascioliasis in Vajamarca/Peru II. Humoral antibody response and antigenaemia. Tropical Medicine and Parasitology 36, 91-93.
9. Levine DM, Hillyer GV & Glores SI (1980) Comparison of CEP, ELISA and Kato faccal examination for diagnosis of fascioliasis in infected mice and rabbits. American Journal of Tropical Medicine and Hygiene 29, 602-608.
10. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ (1951) Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193, 265-275.
11. Maklad MKHI, Khalil HM, El-Sibae MM. Abdalla HM & El-Zayyat EA (1988) Fascioliasis and hepatic affection. Journal of Egyptian Society and Parasitology 18, 1-10.
12. Mott KE & Dixon H (1982) Collaborative study on antigens for immunodiagnosis of schistosomiasis. Bulletin of the World Health Organization 6, 729-753.
13. Osman MM, Zaki A, Abu Samra L, Farag HF & Youssef MM (1992) Evaluation of Fasciola somatic antigenic fractions in the diagnosis of human fascioliasis. Journal of Egyptian Society and Parasitology 22, 27-35.
14. Ragab M & Farag HF (1978) On human fascioliasis in Egypt. Journal of Egyptian Medical Association 61, 773-780.
15. Rivera Marrero CA, Santiago N & Hillyer GV (1988) Evaluation of immunodiagnostic antigens in the excretory-secretory products of fasciola hepatica. Journal of Parasitology 74, 646-652.
16. Salem AI, Abou Basha LM & Farag HF (1987) Immunoglobulin levels and intensity of infection in patients with fascioliasis single or combined with schistosomiasis. Journal of the Egyptian Society and Parasitology 17, 33-40.
17. Voller A, Bidwell DE Se Bartlett A (1975) The enzyme immunoassays in diagnostic medicine. Bulletin of the World Health Organization 53, 55-65.